Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

Acta Otorhinolaryngologica Italica is a prestigious peer-reviewed journal published by PACINI EDITORE, dedicated to advancing the field of otorhinolaryngology. Since its inception in 1981, the journal has established itself as an essential resource for researchers, clinicians, and students interested in the latest developments in ear, nose, and throat medicine. With an impressive Q2 category ranking in the field of Otorhinolaryngology as per Scopus rankings, the journal maintains a significant presence internationally, ranked #39 out of 123 in its category and placing it in the 68th percentile. Acta Otorhinolaryngologica Italica transitioned to an Open Access model in 2018, ensuring that groundbreaking research is accessible to a broader audience, thus fostering collaboration and innovation across the global medical community. With an ongoing commitment to quality and rigor, this journal serves as a valuable platform for disseminating critical findings, case studies, and reviews that contribute to the enhancement of healthcare practices and patient outcomes in otorhinolaryngology.

The Journal of Head & Neck Physicians and Surgeons, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of oncology, oral surgery, otorhinolaryngology, and surgery. Since its transition to Open Access in 2016, the journal has endeavored to disseminate high-quality research and advancements within these specialized areas, fostering collaboration and knowledge sharing among professionals, researchers, and students. With an ISSN of 2347-8128, this journal has established its presence from India and operates with a commitment to rigorous peer review and academic integrity. Despite its relatively recent standing reflected in a Q4 category across several disciplines as well as modest Scopus rankings, the journal's focus on niche scientific studies provides a platform for impactful research to reach practitioners and scholars globally. Continuously adapting to the evolving landscape of medical science, the Journal of Head & Neck Physicians and Surgeons aims to be an essential publication for those aiming to enhance their understanding and clinical practices related to head and neck conditions.

Journal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.

The World Journal of Surgical Oncology, published by BMC, is a leading open-access journal that has been disseminating high-quality research since 2003. With an impressive impact, it currently holds a Q2 ranking in Oncology and a Q1 ranking in Surgery for the year 2023, reflecting its significant contribution to the field. Based in the United Kingdom, this journal serves as a vital platform for researchers, clinicians, and students alike, offering comprehensive coverage on topics ranging from innovative surgical techniques to oncology treatment advancements. As part of the esteemed BMC portfolio, the journal leverages a robust editorial process to ensure the publication of impactful research articles that promote a deeper understanding and enhancement of surgical oncology practices. Its commitment to open access ensures that critical research findings are widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those dedicated to advancing their expertise in surgical oncology, the World Journal of Surgical Oncology is an indispensable resource that reflects the forefront of research and clinical practice.

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

Head & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.